Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851517 | 1.00 | CA1 (0.46) | CA1CA2HPGDLMNATP53 | |
| SCHEMBL24272781 | 0.85 | CA1 (0.47) | CA1CA2HPGDLMNATP53 | |
| SCHEMBL9192345 | 0.83 | CA1 (0.50) | CA1CA2HPGDLMNATP53 | |
| SCHEMBL20696115 | 0.83 | CA1 (0.46) | CA1CA2HPGDLMNATP53 | |
| SCHEMBL7149139 | 0.83 | CA1 (0.46) | CA1CA2HPGDLMNATP53 | |
| SCHEMBL12446362 | 0.82 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL20836640 | 0.82 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL12934956 | 0.82 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL29382066 | 0.82 | CA1 (0.39) | CA1CA2 | |
| SCHEMBL31072319 | 0.82 | CA1 (0.44) | CA1CA2HPGDLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11976017-B2 | Processes for preparing isoprene and mono-olefins comprising at least six carbon atoms | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2024-05-07 | — | — | US | disclosed |
| US-20220402835-A1 | PROCESSES FOR PREPARING ISOPRENE AND MONO-OLEFINS COMPRISING AT LEAST SIX CARBON ATOMS | DOW TECHNOLOGY INVESTMENTS LLC | 2022-12-22 | — | — | US | disclosed |
| US-20220143590-A1 | PROCESS TO PREPARE SOLUTION FROM HYDROFORMYLATION PROCESS FOR PRECIOUS METAL RECOVERY | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2022-05-12 | — | — | US | disclosed |
| EP-3414220-B1 | PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2021-10-13 | — | — | EP | disclosed |
| EP-3143031-B1 | STABILIZED ORGANOPHOSPHOROUS COMPOUNDS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2020-11-04 | — | — | EP | disclosed |
| US-10766839-B2 | Process for converting olefins to alcohols, ethers, or combinations thereof | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2020-09-08 | — | — | US | disclosed |
| EP-3049383-B1 | HYDROFORMYLATION PROCESS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2020-06-24 | — | — | EP | disclosed |
| US-10501486-B2 | Stabilized organophosphorous compounds | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-12-10 | — | — | US | disclosed |
| EP-3356377-B1 | PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-10-23 | — | — | EP | disclosed |
| EP-3356378-B1 | PROCESSES FOR PRODUCING ORGANOPHOSPHOROUS COMPOUNDS | DOW TECHNOLOGY INVESTMENTS LLC (US) | 2019-10-23 | — | — | EP | disclosed |
| WO-1997039997-A1 | PROCESSES FOR PRODUCING 1,6-HEXANEDIOLS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-10-30 | — | — | WO | disclosed |
| WO-1997020794-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997020797-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997020795-A1 | PROCESSES EMPLOYING INDICATOR LIGANDS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997020792-A1 | IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-06-12 | — | — | WO | disclosed |
| WO-1997016466-A1 | POLYURETHANE (METH)ACRYLATES AND PROCESSES FOR PREPARING SAME | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1997-05-09 | — | — | WO | disclosed |
| CN-1029774-C | Rhodium complex hydrogen formylation catalyst and precursor composition of catalyst | UNION CARBIDE CHEM PLASTIC (US) | 1995-09-20 | — | — | CN | disclosed |
| US-4789753-A | FORMYLATION CATALYST COMPLEX | UNION CARBIDE CORPORATION (US) | 1988-12-06 | — | — | US | disclosed |
| US-4737588-A | CONTAINING DIORGANOPHOSPHITE-HYDROFORMYLATION CATALYST | UNION CARBIDE CORPORATION (US) | 1988-04-12 | — | — | US | disclosed |
| US-4717775-A | RHODIUM-DIORGANOPHOSPHITE COMPLEX CATALYZED HYDROFORMYLATION REACTIONS | UNION CARBIDE CORPORATION (US) | 1988-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10501486-B2 | Stabilized organophosphorous compounds | NUDT1, ACHE, PPA1 | CA1 61/4885CA2 178/4885HPGD 3223/4885 |
| US-20220402835-A1 | PROCESSES FOR PREPARING ISOPRENE AND MONO-OLEFINS COMPRISING AT LEAST SIX CARBON ATOMS | ADH5, ADH1C, ADH1A | CA1 1746/4885CA2 2625/4885HPGD 461/4885 |
| US-11976017-B2 | Processes for preparing isoprene and mono-olefins comprising at least six carbon atoms | ADH5, ADH1C, ADH1A | CA1 1746/4885CA2 2625/4885HPGD 461/4885 |
| US-10766839-B2 | Process for converting olefins to alcohols, ethers, or combinations thereof | ADH1C, ADH1A, ADH5 | CA1 2395/4885CA2 2750/4885HPGD 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.